Annual Drug Patent Expirations for OMNARIS
Omnaris is a drug marketed by Covis Pharma Bv and is included in one NDA. It is available from one supplier. There are three patents protecting this drug and one Paragraph IV challenge.
This drug has ninety-seven patent family members in thirty-six countries.
The generic ingredient in OMNARIS is ciclesonide. One supplier is listed for this compound. Additional details are available on the ciclesonide profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com